Klinge Pharma

Name

Klinge Pharma

Legal name

Klinge Pharma GmbH

Website

https://klinge-pharma.com

Company type

Private

Founded year

1933

Operating status

Operating

Headcount range

51–100 employees

Ownership category

akta.pro rank

Product category

Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

OTC & Consumer Health Distributors (HLAIAJAC)

akta.pro secondary industries

OTC Medicines & Consumer Health Products Distribution (CRAOAHAB), Pharmacy Front-End & Sundries Distribution (Health & Wellness, Personal Care, Convenience) (CRAOAHAG)

Keywords

• Prescription pharmaceuticals
• OTC medications
• Dermatology products
• Gastrointestinal health
• Urinary tract treatments

Headquarters

HQ city

Holzkirchen

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Marketing or Sales, Technology or R&D, Operations

Revenue model

1. Pharmaceutical Product Sales: Klinge Pharma manufactures and sells prescription and OTC pharmaceutical products through pharmacy distribution channels in Germany and potentially other markets. Revenue is generated through product sales across their four therapeutic areas: gastrointestinal health, dermatology, venous health, and urinary tract health.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Core offering

Klinge Pharma manufactures and distributes a portfolio of over-the-counter (OTC) and prescription pharmaceutical products through pharmacies in Germany, spanning four therapeutic areas: gastrointestinal health (e.g., Vomex A, Carvomin, Kohle Compretten, Elytro), dermatology (Physiogel, Ketoconazol Klinge), venous health (Venostasin), and urinary tract health (UTIPRO, Arctuvan). The company sells approximately 32 products to pharmacies, which dispense them to end consumers and patients based on prescriptions or self-medication needs.

Product overview

Klinge Pharma is a pharmaceutical company offering a diversified portfolio of over 32 products across four main indication areas: gastrointestinal health (Vomex A, Carvomin, Lingumelt, Kohle Compretten, Ultracarbon, Elytro, DiaVerde), dermatology (Physiogel, Ketoconazol Klinge, Adapaben, Betasacyl, Sumilor), vein health (Venostasin), and urinary tract health (UTIPRO akut & protect, Arctuvan). Additional products include Binko and Binko Memo for memory and circulation, BronchoVerde for respiratory relief, and Vertigo Vomex SR for vertigo. The company also offers training and continuing education services for healthcare professionals through their Fachbereich portal. Products are available both over-the-counter in pharmacies and through prescription.

Differentiator

Problem solved

Functional benefit

Brands

• Vomex A®: Die Nr. 1 bei Übelkeit & Erbrechen. Rezeptfreies Medikament in verschiedenen Darreichungsformen (Dragees, Retardkapseln, Suppositorien, Sirup, Lösung).
• Physiogel®
• Ketoconazol Klinge®
• Venostasin®
• UTIPRO® akut & protect
• Arctuvan®
• Lingumelt® akut
• Kohle Compretten®
• Carvomin® Verdauungstropfen
• Elytro®
• Ultracarbon®
• Binko® / Binko Memo®
• BronchoVerde®
• Vertigo Vomex SR®
• DiaVerde®

Products and services

• Vomex A The number 1 brand in Germany for nausea and vomiting relief (IQVIA Absatz MAT 06/2023), available in multiple dosage forms including dragees, retard capsules, suppositories, syrup, and solution. Sold OTC through pharmacies.
• Physiogel Dermatology product line for dry and sensitive skin, including Daily Moisture Therapy, Calming Relief A.I., Calming Relief, and Scalp Care series. Uses BioMimetic Technology with microbiome-neutral formulations free from fragrance, dyes, silicones, preservatives, and emulsifiers.
• Ketoconazol Klinge Medical shampoo for the prevention and treatment of scalp scaling and seborrheic dermatitis.
• Venostasin

Quantifiable outcome

• Vomex A is the #1 brand for nausea and vomiting in Germany (IQVIA Absatz MAT 06/2023)
• +2 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Three partnerships are on record, tiered core and minor.

• Teva (Klinge-Teva)coreChannel Partner/ Reseller/ Distributor · 2 October 2025Partnership with Teva for major European markets and Israel for Eylea biosimilar (Ahzantive). Settlement with Regeneron secured on October 2, 2025 resolving US patent litigation, permitting US launch in Q4 2026.
• MarpinionminorStrategic or Co-development PartnerCooperation partner for continuing education offerings. Marpinion provides training programs and evening seminars for pharmacists as part of Klinge Pharma's professional education offerings.
• DocCheckcoreTechnology or IntegrationDocCheck provides authentication services for the Fachbereich professional portal. Healthcare professionals must use DocCheck credentials to access prescription product information and professional resources.

Scale indicators6 records

Recent moves8 records

Expansion highlights6 records

Direct peers

• Stada Arzneimittel AG: German-headquartered specialty pharma with a large OTC and generics portfolio distributed through German pharmacies. Closest direct comparable on geography, channel (pharmacy), and product mix (OTC + prescription, branded generics).
• Biologische Heilmittel Heel GmbH: German-based pharma specializing in natural/combination homeopathic and herbal OTC medicines distributed through pharmacies and practitioners. Comparable therapeutic categories (GI, dermatology) and German pharmacy-channel focus.
• Dermapharm Holding SE: German mid-sized pharma focused on branded dermatology, allergy, and pain products sold through pharmacies. Highly comparable on size, growth profile, German pharmacy distribution, and buy-and-build strategy.
• Hermes Arzneimittel GmbH: Privately owned German OTC pharma (Biolectra, doc, Aspecton) distributed through German pharmacies. Highly comparable on size, OTC focus, and family-owned mid-cap profile.
• Engelhard Arzneimittel GmbH & Co. KG: Mid-sized German pharma with OTC brands (e.g., isla-Moos, Sinupret) sold through pharmacies. Comparable on family/mid-cap ownership, pharmacy channel, and OTC therapeutic-area focus.
• Klosterfrau Vertriebsgesellschaft mbH: German heritage pharma company with a portfolio of OTC natural medicine brands (Klosterfrau Melissengeist, Taxofit) sold through pharmacies. Comparable on German focus, OTC brand heritage, and pharmacy channel.

Broad incumbents

• Bayer Consumer Health: Global OTC and consumer-health division of Bayer with major pharmacy brands in Germany. Competes directly on the same German pharmacy shelves but with vastly greater scale, marketing spend, and global pipeline.
• Sanofi Consumer Health (Opella): Global consumer-health business (carved out as Opella) including German OTC brands. Overlaps with Klinge across GI, dermatology, and women's health OTC categories via German pharmacy distribution.
• Merz Pharma GmbH & Co. KGaA: Privately held German pharma across prescription, aesthetics, and consumer health (e.g., tetesept, Merz Spezial). Overlaps with Klinge in OTC consumer health and German pharmacy distribution but is broader in portfolio.
• ratiopharm (Teva): Germany's leading generic and OTC brand owned by Teva, sold through pharmacies. Direct competitor across many of Klinge's OTC categories and connected to Teva via the Klinge-Teva biosimilar partnership.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInde.linkedin.com/company/klinge-pharma
• Instagraminstagram.com/klingepharma

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Klinge Pharma